Stay updated with breaking news from Technology Licensing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.
MICROCLOUD HOLOGRAM INC. AND SUBSIDIARIES UNAUDITED INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS ... -Today at 09:09 am- MarketScreener
A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.
While biofuels show promise in mitigating climate change and fostering energy security, challenges remain in terms of land use, food competition, and...
A new intellectual property and technology transfer director has been named at RIT. Wayne Plourde was appointed to manage entrepreneurial portfolio.